title: Response to "clarification of enrolled subjects in tolvaptan HF trials".
authors.affiliation: 1] Section of Cardiology, Temple University School of Medicine, Philadelphia, Pennsylvania, USA [2] Cardiovascular Research Center, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.
authors.forename: A M
authors.initials: AM
authors.lastname: Feldman
authors.affiliation: Section of Cardiology, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.
authors.forename: E
authors.initials: E
authors.lastname: Hamad
authors.affiliation: 1] Section of Cardiology, Temple University School of Medicine, Philadelphia, Pennsylvania, USA [2] Cardiovascular Research Center, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.
authors.forename: E
authors.initials: E
authors.lastname: Tsai
authors.affiliation: Cardiovascular Research Center, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.
authors.forename: W
authors.initials: W
authors.lastname: Zhu
authors.affiliation: Center for Translational Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.
authors.forename: D G
authors.initials: DG
authors.lastname: Tilley
authors.affiliation: Section of Cardiology, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.
authors.forename: R
authors.initials: R
authors.lastname: Alvarez
authors.affiliation: 1] Center for Translational Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania, USA [2] Section of Nephrology, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.
authors.forename: J Y
authors.initials: JY
authors.lastname: Cheung
mesh_terms: D000818:Animals; D065092:Antidiuretic Hormone Receptor Antagonists; D001127:Arginine Vasopressin / Q000037:antagonists & inhibitors*; D015195:Drug Design; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans
chemical_list: D065092:Antidiuretic Hormone Receptor Antagonists; D001127:Arginine Vasopressin